MERS
The Middle East respiratory syndrome (MERS), was first reported in Saudi
Arabia in 2012. The respiratory illness is caused by a coronavirus, a
distant viral cousin to SARS. It spread to 27 countries in Europe,
Africa, Asia, and North America. Like many coronaviruses, MERS is a
zoonotic virus, which means it is transmitted between animals and
humans. According to scientists, MERS most likely passed from bats into
dromedary camels before jumping to humans. Since 2012, such as in
(figure 3) represented by the chart there have been 2,494 reported cases
of MERS and 858 deaths from the virus. Infections occurred primarily
from close human-to-human contact,
according to the
(WHO). The incubation period (the time between infection and start of
symptoms) is about five days, but it can occasionally be up range from
two to 14 days. There have been no cases of SARS for over a decade. But
MERS is an ongoing public health concern.
MERS-CoV risk factor: the risk of severe infection for MERS-CoV
is the elderly people and those suffering from the second diseases like
heart disease, type one and type two of diabetes and other persons under
the medical conditions like liver disease any person with this
characteristics are at the risk of severe infection with MERS-CoV and
the other persons under the major risk factors like caregivers, nurses
and household contacts, and directly contact with camel body fluids that
exposed to the virus(Alraddadi, Watson et al. 2016).
MERS symptoms and signs : the symptoms begin with fever and mild
cough, and it often made problem in the lungs via severe shortness of
breath and it made disability maintain oxygenation. Those peoples with
severely affected with a fatal type of respiratory failure like adult
respiratory distress syndrome (ARDS). Despite affecting the alveoli of
the lungs also attacking other organs of the body such as kidneys and
heart and become a problem for blood clotting and those people suffering
from autoimmune diseases such as
severe rheumatoid
arthritis(Mailles, Blanckaert, et al. 2013).
treatment for MERS-CoV: Because MERS-CoV is caused by a similar
virus like SARS, the management of MERS-CoV has been extrapolated from
experience with the 2002 SARS outbreak and some limited experimental
data. Like SARS, patients with MERS-CoV often require oxygen
supplementation, and severe cases require mechanical ventilation and
intensive-care-unit support. No medication has been proven to treat
MERS-CoV, and treatment is based upon the patient’s medical condition.
Several medications have been tried in both SARS and MERS-CoV without
conclusive benefits, and further research is to be done. Management of
the individual with MERS is aided by infectious disease, pulmonary, and
critical-care specialists. The common antiviral drugs used at the time
of infectious, against the SARS-COVID1 were like the most effective
medicine. (Greenberg 2016)
vaccine for MERS-CoVNo vaccine is
commercially available at the time of writing.